These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Pigment retinopathy in warmblood horses with equine degenerative myeloencephalopathy and equine motor neuron disease. Finno CJ, Kaese HJ, Miller AD, Gianino G, Divers T, Valberg SJ. Vet Ophthalmol; 2017 Jul; 20(4):304-309. PubMed ID: 27491953 [Abstract] [Full Text] [Related]
63. Amyotrophic lateral sclerosis with mutation of the Cu/Zn superoxide dismutase gene (SOD1) in a patient with Down syndrome. Marucci G, Morandi L, Bartolomei I, Salvi F, Pession A, Righi A, Lauria G, Foschini MP. Neuromuscul Disord; 2007 Oct; 17(9-10):673-6. PubMed ID: 17624778 [Abstract] [Full Text] [Related]
64. [Superoxyde dismutase 1 gene abnormalities in familial amyotrophic lateral sclerosis: phenotype/genotype correlations. The French experience and review of the literature]. Jafari-Schluep HF, Khoris J, Mayeux-Portas V, Hand C, Rouleau G, Camu W, Groupe Français d'Etude des Maladies du Motoneurone. Rev Neurol (Paris); 2004 Jan; 160(1):44-50. PubMed ID: 14978393 [Abstract] [Full Text] [Related]
65. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX. Science; 1994 Jun 17; 264(5166):1772-5. PubMed ID: 8209258 [Abstract] [Full Text] [Related]
67. Copper, zinc superoxide dismutase (SOD1) and its role in neuronal function and disease with particular relevance to motor neurone disease/amyotrophic lateral sclerosis. de Belleroche J, Orrell RW, Virgo L, Habgood J, Gardiner IM, Malaspina A, Kaushik N, Mitchell J, Greenwood J. Biochem Soc Trans; 1998 Aug 17; 26(3):476-80. PubMed ID: 9765899 [No Abstract] [Full Text] [Related]
70. Horses on pasture may be affected by equine motor neuron disease. McGorum BC, Mayhew IG, Amory H, Deprez P, Gillies L, Green K, Mair TS, Nollet H, Wijnberg ID, Hahn CN. Equine Vet J; 2006 Jan 17; 38(1):47-51. PubMed ID: 16411586 [Abstract] [Full Text] [Related]
71. Quantitative assessment of motor neuron loss in equine motor neuron disease (EMND). Weber Polack E, King JM, Cummings JF, de Lahunta A, Divers TJ, Mohammed HO. Equine Vet J; 1998 May 17; 30(3):256-9. PubMed ID: 9622328 [Abstract] [Full Text] [Related]
72. Molecular cloning, expression, and characterization of the Cu,Zn superoxide dismutase (SOD1) gene from the entomopathogenic fungus Cordyceps militaris. Park NS, Lee KS, Sohn HD, Kim DH, Lee SM, Park E, Kim I, Je YH, Jin BR. Mycologia; 2005 May 17; 97(1):130-8. PubMed ID: 16389964 [Abstract] [Full Text] [Related]
73. Cysteine 111 affects aggregation and cytotoxicity of mutant Cu,Zn-superoxide dismutase associated with familial amyotrophic lateral sclerosis. Cozzolino M, Amori I, Pesaresi MG, Ferri A, Nencini M, Carrì MT. J Biol Chem; 2008 Jan 11; 283(2):866-74. PubMed ID: 18006498 [Abstract] [Full Text] [Related]
74. Development and characterization of human and mouse specific antibodies to CuZn-superoxide dismutase (SOD1). Bartlett SE, Singala R, Hashikawa A, Shaw L, Hendry IA. J Neurosci Methods; 2000 May 15; 98(1):63-7. PubMed ID: 10837872 [Abstract] [Full Text] [Related]
77. Association between plasma vitamin E concentration and the risk of equine motor neuron disease. De la Rúa-Domènech R, Mohammed HO, Cummings JF, Divers TJ, De Lahunta A, Summers BA. Vet J; 1997 Nov 15; 154(3):203-13. PubMed ID: 9414953 [Abstract] [Full Text] [Related]
78. Comparing equine motor neuron disease (EMND) with equine grass sickness (EGS). Divers TJ. Equine Vet J; 1999 Mar 15; 31(2):90-1. PubMed ID: 10213417 [No Abstract] [Full Text] [Related]